Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Tadashi Nosaka"'
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Schizophrenia places a great humanistic and financial burden to patients, families, and societies, and the burden is substantially impacted by comorbid conditions. This study aimed to estimate the lifetime prevalence of schizophre
Externí odkaz:
https://doaj.org/article/639103ec8e9f45c7956640e16c41dce5
Autor:
Aditi Kadakia, Carole Dembek, Vincent Heller, Rajpal Singh, Jennifer Uyei, Katsuhiko Hagi, Tadashi Nosaka, Antony Loebel
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background While clinical trial evidence has firmly established the efficacy of several atypical antipsychotics (AAPs) for treating bipolar depression, no randomized controlled trials (RCT’s) comparing AAPs have been conducted. This Bayesi
Externí odkaz:
https://doaj.org/article/292b41010fcd4fe4b9620933f348c4f3
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background The aim of this study was to evaluate the cardio-metabolic risk in schizophrenia patients treated by atypical antipsychotic drugs compared with that in those treated without atypical antipsychotic drugs using a nationwide insuranc
Externí odkaz:
https://doaj.org/article/422994dcd241408781de1417e27d64ee
Publikováno v:
Neuropsychopharmacology Reports, Vol 40, Iss 3, Pp 314-322 (2020)
Abstract Introduction Considering that the efficacy results of the Japan lurasidone phase 3 trials for acute schizophrenia were inconsistent, we conducted a systematic review and a random‐effect model network meta‐analysis of those trials to exam
Externí odkaz:
https://doaj.org/article/9c9fc0bd576d42428a3a705d8735b564
Publikováno v:
Journal of Affective Disorders. 295:203-214
BACKGROUND Previous studies have shown that bipolar disorder (BD) patients frequently present with difficulties in interpersonal relationships, education or employment and suffer poorer quality of life. This study aimed to estimate the impact of BD o
Autor:
Alison L Fitzgerald, Tadashi Nosaka, Masatoshi Nakamura, Yongcai Mao, Keisuke Okamoto, Teruhiko Higuchi, Jun Ishigooka, Masaomi Iyo, Joyce Tsai, Reiko Sakaguchi
Publikováno v:
Psychiatry and Clinical Neurosciences
AIM The aim of this study was to evaluate the efficacy of lurasidone in acute schizophrenia in Japan and other countries. METHODS Subjects (aged 18-74 years) diagnosed with schizophrenia were randomized to lurasidone 40 mg/day or placebo. The primary
Autor:
Rajpal Singh, Antony Loebel, Vincent Heller, Jennifer Uyei, Carole Dembek, Aditi Kadakia, Tadashi Nosaka, Katsuhiko Hagi
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Psychiatry
BMC Psychiatry
Background While clinical trial evidence has firmly established the efficacy of several atypical antipsychotics (AAPs) for treating bipolar depression, no randomized controlled trials (RCT’s) comparing AAPs have been conducted. This Bayesian networ
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Psychiatry
BMC Psychiatry
Background The aim of this study was to evaluate the cardio-metabolic risk in schizophrenia patients treated by atypical antipsychotic drugs compared with that in those treated without atypical antipsychotic drugs using a nationwide insurance claims
Publikováno v:
Neuropsychiatric Disease and Treatment
Yoshiteru Takekita,1 Sachie Inoue,2 Kenji Baba,3 Tadashi Nosaka3 1Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan; 2CRECON Medical Assessment Inc, Tokyo, Japan; 3Sumitomo Dainippon Pharma Co, Ltd, Tokyo, JapanCorrespondence: Yo
Publikováno v:
BMC psychiatry. 22(1)
Background Schizophrenia places a great humanistic and financial burden to patients, families, and societies, and the burden is substantially impacted by comorbid conditions. This study aimed to estimate the lifetime prevalence of schizophrenia and t